BioInvent International AB(GB:0H22)
kr 3.000.00 (0.00%)
GB:0H22
BioInvent International AB financials statements
kr 3.00
At close:0.00 (0.00%)
BioInvent International AB (0H22) Financial Statements
1 Followers
BioInvent International AB Financial Overview
BioInvent International AB's market cap is currently kr201.36M. The company's EPS TTM is kr-7.40; its P/E ratio is -0.41; BioInvent International AB is estimated to report earnings on March 4, 2027, and the estimated EPS forecast is kr-1.07. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | kr 226.50M | kr 44.69M | kr 71.46M | kr 326.13M | kr 19.38M |
| Gross Profit | kr 226.50M | kr 44.69M | kr 71.46M | kr 326.13M | kr 19.38M |
| Operating Income | kr -351.39M | kr -471.06M | kr -369.94M | kr -50.92M | kr -278.35M |
| EBITDA | kr -331.52M | kr -409.38M | kr -312.71M | kr -27.13M | kr -263.32M |
| Net Income | kr -332.86M | kr -429.38M | kr -330.30M | kr -34.09M | kr -278.96M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | kr 592.75M | kr 867.16M | kr 1.07B | kr 1.02B | kr 1.08B |
| Total Assets | kr 671.20M | kr 989.24M | kr 1.40B | kr 1.71B | kr 1.45B |
| Total Debt | kr 9.68M | kr 17.41M | kr 23.24M | kr 26.96M | kr 28.37M |
| Net Debt | kr -346.49M | kr -417.41M | kr -236.30M | kr -488.08M | kr -882.39M |
| Total Liabilities | kr 113.59M | kr 103.42M | kr 90.45M | kr 106.09M | kr 80.32M |
| Stockholders' Equity | kr 557.62M | kr 885.82M | kr 1.31B | kr 1.61B | kr 1.37B |
| Cash Flow | |||||
| Free Cash Flow | kr -255.01M | kr -390.50M | kr -355.00M | kr -53.60M | kr -259.10M |
| Operating Cash Flow | kr -247.75M | kr -380.47M | kr -341.69M | kr -41.23M | kr -245.84M |
| Investing Cash Flow | kr 180.13M | kr 564.35M | kr 59.68M | kr -628.85M | kr -467.54M |
| Financing Cash Flow | kr -8.98M | kr -8.46M | kr 23.14M | kr 273.49M | kr 894.87M |
Currency in SEK
